Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Bio-Path Holdings Inc (BPTH)

Pharmaceutical Preparations

https://www.biopathholdings.com

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.

4710 BELLAIRE BOULEVARD, SUITE 210
BELLAIRE, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/04/2008

Market Cap

3,821,905

Shares Outstanding

12,350,000

Weighted SO

12,352,664

Total Employees

N/A

Upcoming Earnings

08/20/2024

Similar Tickers

CBIO --.--%

DFFN --.--%

CAPR --.--%

NXTC --.--%

PULM --.--%

BLPH --.--%

CRNX --.--%

AMTI --.--%

ALRN --.--%

Beta

0.2830

Last Div

0.0000

Range

1.31-21.6

Chg

0.0075

Avg Vol

1127777

Mkt Cap

3821905

Exch

NASDAQ

Country

US

Phone

832 742 1357

DCF Diff

-0.4669

DCF

1.9644

Div Yield

0.0000

P/S

13.9486

EV Multiple

0.0102

P/FV

1.8698

Div Yield %

0.0000

P/E

-0.2082

PEG

-0.0180

Payout

0.0000

Current Ratio

1.6674

Quick Ratio

1.6674

Cash Ratio

1.3309

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

1684.2771

CCC

-1684.2771

Gross Margin

0.3942

Op Margin

-47.5985

Pretax Margin

-42.3248

Net Margin

-42.3248

Eff Tax Rate

-0.0229

ROA

-2.2659

ROE

-28.4240

ROCE

-6.1869

NI/EBT

1.0000

EBT/EBIT

0.8892

EBIT/Rev

-47.5985

Debt Ratio

0.0107

D/E

0.0426

LT Debt/Cap

0.0000

Total Debt/Cap

0.0409

Int Coverage

-686.4211

CF/Debt

-161.1091

Equity Multi

3.9644

Rec Turnover

0.0000

Pay Turnover

0.2167

Inv Turnover

0.0000

FA Turnover

2.7677

Asset Turnover

0.0535

OCF/Share

-5.4969

FCF/Share

-5.4969

Cash/Share

2.4851

OCF/Sales

-32.3394

FCF/OCF

1.0000

CF Coverage

-161.1091

ST Coverage

-161.1091

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.8698

P/B

1.8698

P/S

13.9486

P/E

-0.2082

P/FCF

-0.4313

P/OCF

-0.2724

P/CF

-0.2724

PEG

-0.0180

P/S

13.9486

EV Multiple

0.0102

P/FV

1.8698

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 09, 00:00 Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Revenue Product Segmentation